National Medicines Regulatory Authority (NMRA) Director General and Chief Executive Officer (CEO) Dr. Vijith Gunasekara has been removed from his position. Health Ministry Secretary S. Janaka Chandraguptha said that based on a decision made by the NMRA Board of Directors, Dr. Vijith Gunasekara had been removed from the position of Director General and CEO of NMRA.
Following this decision and subsequent to the removal, Dr. Vijith Gunasekara has been recalled to the Health Ministry, Health Ministry Secretary Chandraguptha said.
NMRA officials including CEO Chandraguptha had been recently accused of importing a batch of substandard human intravenous immunoglobulin (IVIG) into Sri Lanka.
Dr. Ananda Wijewickrama was appointed as the Chairman of the National Medicines Regulatory Authority recently.
However, Dr. Vijith Gunasekara continued as Director General and Chief Executive Officer at NMRA after the alleged incident of the unlawful importing of a substandard batch of IVIG vials and was also accused of shredding a series of confidential sensitive NMRA official documents.
A complaint with regards to this incident had also been filed with the Criminal Investigation Department.
The post NMRA DG and CEO removed appeared first on DailyNews.